68Ga-Prostate-Specific Membrane Antigen Uptake in a Pancreatic Neuroendocrine Tumor.


Journal

Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109

Informations de publication

Date de publication:
May 2020
Historique:
pubmed: 10 3 2020
medline: 28 8 2020
entrez: 10 3 2020
Statut: ppublish

Résumé

We present a 60-year-old man with known prostate cancer treated with robot-assisted radical prostatectomy. Prostate-specific antigen levels did not decline accordingly, and a second Ga-PSMA PET/CT demonstrated a new focus with high Ga-PSMA uptake in the pancreatic tail. A subsequent CT scan did not display the lesion as a typical pancreatic tumor, and a spleen scintigraphy was also negative excluding an ectopic intrapancreatic accessory spleen. Ga-DOTATOC PET/CT showed uptake in the same area of the pancreatic tail consistent with a neuroendocrine tumor. This case illustrates that neuroendocrine tumors can be important pitfalls in Ga-PSMA PET/CT performed in prostate cancer patients.

Identifiants

pubmed: 32149792
doi: 10.1097/RLU.0000000000002997
pii: 00003072-202005000-00010
doi:

Substances chimiques

Gallium Isotopes 0
Gallium Radioisotopes 0
Membrane Glycoproteins 0
Organometallic Compounds 0
gallium 68 PSMA-11 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

379-382

Références

Bhutiani N, Egger ME, Doughtie CA, et al. Intrapancreatic accessory spleen (IPAS): a single-institution experience and review of the literature. Am J Surg. 2017;213:816–820.
Li BQ, Xu XQ, Guo JC. Intrapancreatic accessory spleen: a diagnostic dilemma. HPB (Oxford). 2018;20:1004–1011.
Santos MPD, Rezende AP, Santos PVDF, et al. Intrapancreatic accessory spleen. Einstein (Sao Paulo). 2017;15:366–368.
Collarino A, del Ciello A, Perotti G, et al. Intrapancreatic accessory spleen detected by 68Ga DOTANOC PET/CT and 99mTc-colloid SPECT/CT scintigraphy. Clin Nucl Med. 2015;40:415–418.
Engler CC, Lemke J, Kornmann M, et al. Ectopic spleen and liver hemangioma mimicking metastatic pancreatic neuroendocrine tumor. Int J Surg Case Rep. 2015;17:139–142.
Vamadevan S, Shetty D, Le K, et al. Prostate-specific membrane antigen (PSMA) avid pancreatic neuroendocrine tumor. Clin Nucl Med. 2016;41:804–806.
Merkle EM, Boaz T, Kolokythas O, et al. Metastases to the pancreas. Br J Radiol. 1998;71:1208–1214.
Glinka J, Sanchez Claria R, Ardiles V, et al. The pancreas as a target of metastasis from renal cell carcinoma: results of surgical treatment in a single institution. Ann Hepatobiliary Pancreat Surg. 2019;23:240–244.
Minni F, Casadei R, Perenze B, et al. Pancreatic metastases: observations of three cases and review of the literature. Pancreatology. 2004;4:509–520.
Jacob J, Chargari C, Bauduceau O, et al. Pancreatic metastasis from prostate cancer. Case Rep Med. 2010;2010:826273.
Volmar KE, Jones CK, Xie HB. Metastases in the pancreas from nonhematologic neoplasms: report of 20 cases evaluated by fine-needle aspiration. Diagn Cytopathol. 2004;31:216–220.
Epstein JI, Amin MB, Beltran H, et al. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation. Am J Surg Pathol. 2014;38:756–767.
Chen S, Cheung SK, Wong KN, et al. 68Ga-DOTATOC and 68Ga-PSMA PET/CT unmasked a case of prostate cancer with neuroendocrine differentiation. Clin Nucl Med. 2016;41:959–960.
Sheikhbahaei S, Werner RA, Solnes LB, et al. Prostate-specific membrane antigen (PSMA)–targeted PET imaging of prostate cancer: an update on important pitfalls. Semin Nucl Med. 2019;49:255–270.
Backhaus P, Noto B, Avramovic N, et al. Targeting PSMA by radioligands in non–prostate disease—current status and future perspectives. Eur J Nucl Med Mol Imaging. 2018;45:860–877.
Shetty D, Patel D, Le K, et al. Pitfalls in gallium-68 PSMA PET/CT interpretation—a pictorial review. Tomography. 2018;4:182–193.

Auteurs

Thien Vinh Luong (TV)

From the Department of Nuclear Medicine and PET-Centre, Aarhus University Hospital, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH